Oculis Holding AG
corporate_fare Company Profile
Oculis Holding AG (NASDAQ:OCS) is a publicly traded company in the Life Sciences sector. Wiseek monitors OCS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Shareholder Investigation Launched Against Oculis Over Alleged Misleading Statements on Failed Drug Trial
- Oculis' OCS-01 Fails Phase 3 DIAMOND Trials for Diabetic Macular Edema; FDA Filing Abandoned
- Oculis' OCS-01 Drug Fails Phase 3 Trial for Diabetic Macular Edema; FDA Filing Halted
- Oculis Shareholders Approve Large Capital Band, Authorizing Significant Future Dilution
- Oculis Secures EMA PRIME Designation for Privosegtor, Advances Key Clinical Trials
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$98.96M
Diluted EPS
-$1.89
Op. Cash Flow
-$66.3M
Free Cash Flow
-$66.61M
Operating Income
-$81.67M
Cash & Equivalents
$81.33M
Debt / Equity
0.00×
Source: 20-F · filed 2026-03-04 · accession 0001193125-26-091446
Insider Transactions
OCS files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed OCS - Latest Insights
OCS
Jun 02, 2026, 9:00 AM EDT
Price at Filing:
$13.94
Real-time Price:
$11.25
Change:
-$2.69 (-19%)
Market Cap:
$634.009M
OCS
May 29, 2026, 5:54 PM EDT
Price at Filing:
$14.30
Real-time Price:
$11.25
Change:
-$3.05 (-21%)
Market Cap:
$634.009M
OCS
May 29, 2026, 3:01 PM EDT
Price at Filing:
$22.71
Real-time Price:
$11.25
Change:
-$11.45 (-50%)
Market Cap:
$634.009M
OCS
May 14, 2026, 4:05 PM EDT
Price at Filing:
$30.22
Real-time Price:
$11.25
Change:
-$18.97 (-63%)
Market Cap:
$634.009M
OCS
May 11, 2026, 4:07 PM EDT
Price at Filing:
$32.65
Real-time Price:
$11.25
Change:
-$21.40 (-66%)
Market Cap:
$634.009M
OCS
May 11, 2026, 4:05 PM EDT
Price at Filing:
$32.65
Real-time Price:
$11.25
Change:
-$21.40 (-66%)
Market Cap:
$634.009M
OCS
May 07, 2026, 4:57 AM EDT
Price at Filing:
$29.58
Real-time Price:
$11.25
Change:
-$18.33 (-62%)
Market Cap:
$634.009M
OCS
Apr 21, 2026, 4:10 PM EDT
Price at Filing:
$27.38
Real-time Price:
$11.25
Change:
-$16.13 (-59%)
Market Cap:
$634.009M
OCS
Mar 31, 2026, 4:00 AM EDT
Price at Filing:
$24.40
Real-time Price:
$11.25
Change:
-$13.15 (-54%)
Market Cap:
$634.009M
OCS
Mar 04, 2026, 4:31 PM EST
Price at Filing:
$27.72
Real-time Price:
$11.25
Change:
-$16.47 (-59%)
Market Cap:
$634.009M
OCS
Mar 04, 2026, 4:19 PM EST
Price at Filing:
$27.85
Real-time Price:
$11.25
Change:
-$16.60 (-60%)
Market Cap:
$634.009M
OCS
Mar 04, 2026, 4:01 PM EST
Oculis Reports Strong Cash Position and Advances Multiple Drug Candidates into Registrational Trials
Price at Filing:
$27.72
Real-time Price:
$11.25
Change:
-$16.47 (-59%)
Market Cap:
$634.009M
OCS
Mar 03, 2026, 4:05 PM EST
Price at Filing:
$28.38
Real-time Price:
$11.25
Change:
-$17.13 (-60%)
Market Cap:
$634.009M